Entrada Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol: TRDA on Nasdaq
Industry: Pharmaceutical Preparations
Location: One Design Center Place, Suite 17 500, Boston, MA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+3.4M	94.2%	$14.85	+$50.4M
Sells	6	-209K	5.8%	$18.72	-$3.92M
Net	-4	+3.19M	88.4%		+$46.5M

Entrada Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Mpm Bioventures 2018, L.P.	10%+ Owner	$88.6M	-$917K	-1.02%	Dec 10, 2024
MPM BioVentures 2014, L.P.	10%+ Owner	$88.6M	-$917K	-1.02%	Dec 10, 2024
Todd Foley	Director, 10%+ Owner	$70.8M			Jun 2, 2022
Baker Bros. Advisors Lp	10%+ Owner	$45.8M	+$50M		Jun 25, 2024
Roche Holding Ltd	10%+ Owner	$45M			Nov 2, 2021
Redmile Group, LLC	10%+ Owner	$31.3M			Nov 2, 2021
5AM Ventures V, L.P.	10%+ Owner	$18.1M			Nov 2, 2021
Dipal Doshi	CEO, Director	$4.96M	-$95.2K	-1.88%	Mar 1, 2025
Natarajan Sethuraman	President, Research & Develop.	$2.33M	-$1.11M	-32.3%	Mar 1, 2025
Nathan J. Dowden	President & COO	$2.11M	-$489K	-18.8%	Mar 1, 2025
Peter S. Kim	Director	$1.58M	+$428K	+37%	Jun 13, 2024
Nerissa Kreher	Chief Medical Officer	$640K			Sep 1, 2023
Kory James Wentworth	Chief Financial Officer	$253K	-$386K	-60.3%	Apr 3, 2025
Gina Chapman	Director				Jun 13, 2024
Mary Thistle	Director				Jun 13, 2024
Carole Nuechterlein	Director				Jun 2, 2022
Kush Parmar	Director, 10%+ Owner				Jun 13, 2024
John F. Crowley	Director				Jun 8, 2023
Bernhardt G. Zeiher	Director				Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for Entrada Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.